👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆Pehle mujhe lagta tha ki medicine labels par likha hua
“Store in a cool, dry place”
bas ek formal suggestion hota hai.
Nahi.
Ye actually 12-month ki multi-batch, multi-condition stability study ka final conclusion hota hai.
Aur agar aapne isse ignore kiya, to tablet ke molecules chup-chaap degrade hona start kar dete hain — aur dheere-dheere wo same drug rehti hi nahi.
Yahi kaam karta hai Stability Testing.
Aur honestly, pharma education ka ye shayad sabse under-explained topic hai.
Pichle kuch dino se maine pura ICH Q1A–Q1F framework condense karke ek single visual one-pager banaya — exactly waise notes jaisa resource kaash M.Pharm ke first semester me kisi ne mujhe diya hota.
Aur is process me kuch cheezein samajh aayi jo normally books seedha nahi batati:
→ India Climatic Zone IVa me aata hai — matlab hot bhi aur humid bhi.
Boston me stable drug ka Bareilly me stable rehna guaranteed nahi hota. Isi liye regional stability data important hota hai.
→ Accelerated testing (40°C / 75% RH for 6 months) sirf ek preview hai, replacement nahi.
Actual expiry date legally sirf long-term real-time data hi decide karta hai.
→ Assay me sirf 5% drop bhi batch fail kara sakta hai.
10% nahi.
“Thoda weak lag raha hai” wala concept nahi.
Bas 5%.
Total 12 sections cover kiye hain — study types, climatic zones, workflow, significant change criteria, aur kuch aise myths jo vivas me unnecessarily repeat hote rehte hain.